Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Medicine Prescription Chantix is a blockbuster

Released on = November 27, 2006, 2:52 am

Press Release Author = olivia andrews

Industry = Pharmaceuticals

Press Release Summary = Chantix has provided with great results in comparison to
other smoking cessation drugs along with no drug abuse associated with it.

Press Release Body = In the U.S. smoking remains the biggest cause of death and
nearly 70 percent of the people smoking in the nation say that they really want to
quit smoking. The astonishing fact remains that the treatments that exist work
poorly whereas Chantix has shown superior performance.

Until now estimates figure out that Chantix may account for more than $1 billion of
sales in a year and these sales rose up to $33 million while the drug was launched
during the days in summer. The results of Chantix are found to be striking because
in spite of the fact that it has very little marketing support from the company and
other related criticism of the drugs, it was made advertised directly to the
consumers until they have been marketed for a period of six months.

Chantix works by deadening cravings for cigarettes and blocking the effects of
nicotine on the brain. The FDA approved Chantix in just six months, citing its
“significant potential” to improve public health. In clinical tests sponsored by
Pfizer, more than 40 percent of Chantix users were smoke-free at 12 weeks, compared
with about 30 percent taking Zyban, an antidepressant sold as an aid to smoking
cessation. After a year, the smoke-free Chantix users slipped to about 20 percent,
not significantly better than Zyban\'s results but still twice as good as the results
of those taking a placebo.

According to Dr. Rodriguez who has prescribed Chantix to four of its patients
prefers it in comparison to Zyban as patients who tried Chantix found it extremely
helpful. Unlike the nicotine-replacement, products or anti-anxiety drugs long
prescribed for smokers trying to quit, Chantix works by binding to the same
receptors in your brain that nicotine does, decreasing cravings for cigarettes.

Please do visit our website http://www.benzer11.com/chantix.html to know more about
chantix medicine.


Web Site = http://www.benzer11.com

Contact Details = Binghamton, NY 13902
(607) 722-1734
webmaster@benzer11.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •